News

AUROBAC THERAPEUTICS welcomes two new independent members to its Board: Manos Perros, as Chairman, and Marco Taglietti

These new appointments bring extensive US and international experience in company leadership and development of anti-infectives from R&D to commercialization.Lyon…

1 year ago

Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers This comprehensive model is…

1 year ago

DLH to Announce Fiscal 2023 Third Quarter Financial Results

ATLANTA, July 24, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and…

1 year ago

Applied UV’s Subsidiary, PURO, and Its Partner Academy Energy Group (AEG), Have Been Selected As a Finalist for the GSA’s Green Proving Ground (GPG) Program

Germicidal Ultraviolet, PURO with its Partner Academy Energy Group – Using next-generation LEDs and Far-UVC light to disinfect air without…

1 year ago

Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension

Keros Therapeutics announces U.S. Food and Drug Administration (“FDA”) has cleared its investigational new drug application to conduct a Phase…

1 year ago

Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors

– Ms. Tomasello created and led global commercial and medical affairs functions at Kite Pharma from pre-launch through its acquisition…

1 year ago

ZyVersa Therapeutics, Inc. Announces Pricing of $2.1 Million Public Offering

WESTON, Fla., July 24, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa” or “the Company”), a clinical…

1 year ago

Ocular Therapeutix™ To Report Second Quarter 2023 Financial Results

BEDFORD, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and…

1 year ago

Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement

REDWOOD CITY, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing…

1 year ago

Inspire Medical Systems, Inc. Announces Appointment of Carlton Weatherby as Chief Strategy Officer

MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on…

1 year ago